REGENERON PHARMACEUTICALS, INC. Payments for (Proceeds from) Other Investing Activities
REGENERON PHARMACEUTICALS, INC. (REGN) reported Payments for (Proceeds from) Other Investing Activities of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2021-02-08
- REGENERON PHARMACEUTICALS, INC. payments for (proceeds from) other investing activities for the quarter ending 2019-12-31 was $0.00.
- REGENERON PHARMACEUTICALS, INC. payments for (proceeds from) other investing activities for the quarter ending 2018-12-31 was $0.00.
- REGENERON PHARMACEUTICALS, INC. payments for (proceeds from) other investing activities for the quarter ending 2017-12-31 was $0.00.
- REGENERON PHARMACEUTICALS, INC. payments for (proceeds from) other investing activities for fiscal 2020 was $0.00.
- REGENERON PHARMACEUTICALS, INC. payments for (proceeds from) other investing activities for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- REGENERON PHARMACEUTICALS, INC. payments for (proceeds from) other investing activities for fiscal 2018 was $10.00M.
- REGENERON PHARMACEUTICALS, INC. payments for (proceeds from) other investing activities for fiscal 2017 was $0.00.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 9 month | Payments for (Proceeds from) Other Investing Activities 12 month |
|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-08 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-08 | $0.00 10-K · filed 2021-02-08 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-05 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-08 | $10.00M 10-K · filed 2021-02-08 | |
| 2018-09-30 | $10.00M 10-Q · filed 2019-11-05 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $0.00 10-K · filed 2020-02-07 | |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-06 | ||
| 2016-12-31 | $0.00 10-K · filed 2019-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |